InspireMD Inc reports results for the quarter ended in March - Earnings Summary

InspireMD

16/05/2023 13:02

* InspireMD Inc  NSPR.OQ  reported a quarterly adjusted loss
of 53
cents​​ per share for the quarter ended in March. The lone
analyst forecast for the quarter was for a loss of 68 cents per
share.
    * Revenue rose 4.7% to $1.24 million from a year ago;
analysts
expected $1.00 million. 
    * InspireMD Inc's reported EPS for the quarter was a loss
of 53
cents​.
    * The mean earnings estimate of analysts had risen by
about 16% in
the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * InspireMD Inc shares had risen by 62.8% this quarter and
gained 114.1% so far this year.
    * The company reported a quarterly loss of $4.26 million.
    * Wall Street's median 12-month price target for InspireMD
Inc is
$5.15 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
16 at 12:02 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.68          -0.53          Beat
 Dec. 31 2022      -0.84          -0.60          Beat
 Sep. 30 2022      -0.73          -0.58          Beat
 Jun. 30 2022      -0.73          -0.59          Beat